Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Catalent Invests $7.3M at Aprilia, Italy Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News

Catalent Invests $7.3M at Aprilia, Italy Facility

Expands Softgel Encapsulation and Packaging Capabilities

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Catalent Pharma Solutions has completed the first phase of a $7.3 million investment to upgrade and expand its packaging and softgel encapsulation capabilities at its facility in Aprilia, Italy.
 
The first phase, completed in August 2018, expanded and upgraded the facility’s integrated packaging capabilities, and commissioned the first of five new softgel encapsulation lines. The second phase to add a further four encapsulation lines, will bring the total number of lines to 23 and significantly expand production, drying, and inspection capacity for nutritional supplements and beauty softgels at the site. These four new lines are expected to be fully operational by January 2019.
 
“We have a long and proud history in softgel product development and commercial manufacturing,” commented Dr. Aris Gennadios, president of Catalent Softgel Technologies. “This investment is driven by increasing demand for nutritional and beauty products globally, and will enable Catalent to better serve these markets.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics